Zonisamide Capsule
Product Images NDC 71335-2797

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 71335-2797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 01)

Chemical structure of zonisamide, a sulfonamide derivative with benzisoxazole core linked to a sulfonamide group (CH2SO2NH2).*

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)

A cumulative distribution plot comparing the percentage reduction in all partial seizure rates between patients taking Zonisamide capsules and those taking a placebo, with the x-axis showing the percentage of patients and the y-axis showing percent reduction, indicating levels of improvement or worsening.*

FDA Label Image

Label (Lbl713352797)

The label for Zonisamide Capsules, USP 100 mg, oral dosage form, shows a package containing 100 capsules. The label includes the NDC 71335-2797-1 and indicates the product is repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA, and manufactured by Zydus Lifesciences Ltd. Storage instructions and child resistance warning are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.